Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's Disease

Recent news which mentions Alzheimer's Disease

< Previous 1 2 3 Next >
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Cannabis-Based Dronabinol Could Transform Alzheimer's Care, New Study Finds
Tickers NEWS
Tags John Hopkings University medical cannabis neurodegenerative disease
From Benzinga
Shark Tank's Barbara Corcoran Reveals Her Struggle With Alzheimer's In Her Family
Tickers NEWS
Tags Psychology News Top Stories
From Benzinga
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Health & Science Breaking News: Business Business News
From CNBC.com News
Midsummer News Flashes – Good and Not So Good
Tags Alzheimer's Disease C2N Diagnostics Zika
From Stock Gumshoe
Alzheimer’s and Parkinson’s Tests and Treatments… plus a Quick COVID-19 (and Long COVID) Update
Tags Doc Gumshoe coronavirus Alzheimer's Disease
From Stock Gumshoe
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
Tickers ALS NEWS WENA
Tags Market News Pre/Market Outlook Parkinson's Disease
From Benzinga
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Tickers LLY NEWS
Tags Market News LLY Health Care
From Benzinga
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Tesla Inc Inflation Nasdaq Inc
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Daily Open Asia Markets Eli Lilly and Co
From CNBC.com News
EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
Tags Exclusive Health Care Top Stories
From Benzinga
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
Tags Alzheimer's disease Long/Term Care Your Money
From CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
Tickers BIIB IONS NEWS
Tags Stories That Matter Benzinga Alzheimer's disease
From Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
Tickers CBD
Tags General Cannabis Market News
From Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Tickers ACIU BIIB ESAIY ESALY
Tags ESAIY BIIB PRTA
From Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
Tags Alzheimer's disease Health Dementia
From CNBC.com News
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
Tickers TECH
Tags Markets ASD Market News
From Benzinga
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
Tags Health Alzheimer's disease Podcasting
From CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
Tickers POTX TOKE
Tags Market News Cannabis Markets
From Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
Tags Retirement planning Retirement Elder care
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Biotech and Pharmaceuticals Eli Lilly and Co Eisai Co Ltd
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Alzheimer's disease Science Business
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Biotech and Pharmaceuticals Regulations Eisai Co Ltd
From CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
Tickers ALZN BIIB LLY SAVA
Tags BIIB Market News Top Stories
From Benzinga
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Health & Science Breaking News: Business Business News
From CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
Tags Amprion Abbvie (ABBV) Migraine
From Stock Gumshoe
Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
Tags FloraWorks sleep disorders Exclusives
From Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Politics Biotech and Pharmaceuticals Policy
From CNBC.com News
Medicare details plan to cover Alzheimer's treatments
Tags Policy U/S/ Economy Health care industry
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Biogen Inc Biotechnology US: News
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.